ATE237345T1 - Verwendung von citrullin enthaltenden peptiden, die von filaggrin abstammen, zur behandlung von autoimmunkrankheiten - Google Patents
Verwendung von citrullin enthaltenden peptiden, die von filaggrin abstammen, zur behandlung von autoimmunkrankheitenInfo
- Publication number
- ATE237345T1 ATE237345T1 AT98964537T AT98964537T ATE237345T1 AT E237345 T1 ATE237345 T1 AT E237345T1 AT 98964537 T AT98964537 T AT 98964537T AT 98964537 T AT98964537 T AT 98964537T AT E237345 T1 ATE237345 T1 AT E237345T1
- Authority
- AT
- Austria
- Prior art keywords
- filaggrin
- treatment
- autoimmune diseases
- peptides derived
- containing peptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Rehabilitation Therapy (AREA)
- Marine Sciences & Fisheries (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9716672A FR2773078B1 (fr) | 1997-12-30 | 1997-12-30 | Utilisation de peptides citrullines derives de la filaggrine pour le traitement de la polyarthrite rhumatoide |
PCT/FR1998/002900 WO1999034819A2 (fr) | 1997-12-30 | 1998-12-29 | Utilisation de peptides citrullines derives de la filaggrine dans le cadre du traitement de maladies autoimmunes |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE237345T1 true ATE237345T1 (de) | 2003-05-15 |
Family
ID=9515271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98964537T ATE237345T1 (de) | 1997-12-30 | 1998-12-29 | Verwendung von citrullin enthaltenden peptiden, die von filaggrin abstammen, zur behandlung von autoimmunkrankheiten |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1041997B1 (de) |
JP (1) | JP4557421B2 (de) |
AT (1) | ATE237345T1 (de) |
AU (1) | AU1971899A (de) |
CA (1) | CA2315294C (de) |
DE (1) | DE69813620T2 (de) |
DK (1) | DK1041997T3 (de) |
ES (1) | ES2193601T3 (de) |
FR (1) | FR2773078B1 (de) |
WO (1) | WO1999034819A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2900657B1 (fr) | 2006-05-03 | 2009-04-17 | Univ Toulouse | Identification de modulateurs de l'activation des macrophages, utilisables pour le traitement de la polyarthrite rhumatoide |
FR2908134B1 (fr) * | 2007-12-04 | 2012-10-12 | Univ Toulouse 3 Paul Sabatier | Identification de modulateurs de l'activation des macrophages, utilisables pour le traitement de la polyarthrite rhumatoide |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3307636B2 (ja) * | 1990-01-31 | 2002-07-24 | ボード オブ リージェンツ オブ ザ ユニバーシティ オブ オクラホマ | 自己免疫疾患のためのアッセイおよび治療 |
JP4162259B2 (ja) * | 1991-04-26 | 2008-10-08 | ビオメリュー・ソシエテ・アノニム | リウマチ性関節炎抗体により認識される抗原、抗原製剤及びその適用方法 |
WO1994017411A1 (en) * | 1993-01-27 | 1994-08-04 | Duke University | Methods and agents for the diagnosis and treatment of rheumatoid arthritis |
FR2752842B1 (fr) * | 1996-08-30 | 1998-11-06 | Biomerieux Sa | Antigenes derives des filaggrines et leur utilisation pour le diagnostic de la polyarthrite rhumatoide |
NL1004539C2 (nl) * | 1996-11-15 | 1998-05-20 | Stichting Tech Wetenschapp | Peptide afgeleid van een door auto-antilichamen van patiënten met reumatoïde artritis herkend antigeen, antilichaam daartegen en werkwijze voor het detecteren van auto-immuunantilichamen. |
AU2155899A (en) * | 1997-11-28 | 1999-06-16 | Innogenetics N.V. | Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment |
FR2773157B1 (fr) * | 1997-12-30 | 2001-10-05 | Bio Merieux | Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide |
-
1997
- 1997-12-30 FR FR9716672A patent/FR2773078B1/fr not_active Expired - Fee Related
-
1998
- 1998-12-29 DE DE69813620T patent/DE69813620T2/de not_active Expired - Lifetime
- 1998-12-29 WO PCT/FR1998/002900 patent/WO1999034819A2/fr active IP Right Grant
- 1998-12-29 AU AU19718/99A patent/AU1971899A/en not_active Abandoned
- 1998-12-29 ES ES98964537T patent/ES2193601T3/es not_active Expired - Lifetime
- 1998-12-29 JP JP2000527267A patent/JP4557421B2/ja not_active Expired - Fee Related
- 1998-12-29 DK DK98964537T patent/DK1041997T3/da active
- 1998-12-29 EP EP98964537A patent/EP1041997B1/de not_active Expired - Lifetime
- 1998-12-29 CA CA2315294A patent/CA2315294C/fr not_active Expired - Fee Related
- 1998-12-29 AT AT98964537T patent/ATE237345T1/de active
Also Published As
Publication number | Publication date |
---|---|
CA2315294C (fr) | 2012-07-03 |
JP2002500195A (ja) | 2002-01-08 |
EP1041997A2 (de) | 2000-10-11 |
FR2773078A1 (fr) | 1999-07-02 |
DE69813620D1 (de) | 2003-05-22 |
WO1999034819A3 (fr) | 1999-11-04 |
DE69813620T2 (de) | 2004-02-12 |
JP4557421B2 (ja) | 2010-10-06 |
AU1971899A (en) | 1999-07-26 |
WO1999034819A2 (fr) | 1999-07-15 |
DK1041997T3 (da) | 2003-08-04 |
EP1041997B1 (de) | 2003-04-16 |
ES2193601T3 (es) | 2003-11-01 |
FR2773078B1 (fr) | 2000-05-26 |
CA2315294A1 (fr) | 1999-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0204199A2 (hu) | Transzport vektorok | |
EP1194164A4 (de) | Prion protein peptide und deren verwendung | |
IL125590A0 (en) | Peptide immunogens | |
BR0213786A (pt) | Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células | |
AU1049788A (en) | Methods and peptides for the treatment of non-ige-mediated diseases | |
BG101966A (en) | Application of 1l-agonist for the treatment of lack of urine retention | |
ATE334694T1 (de) | Verwendung von thymulinähnlichen peptiden zur herstellung von schmerzmitteln | |
DE69533704D1 (de) | Bradykinin-antagonist peptide mit n-substituierten glycinen | |
PT848720E (pt) | Antagonistas da actividade oncogenica da proteina mdm2 e sua utilizacao no tratamento de cancros | |
NL300830I2 (nl) | Protein Q, een recombinant chimeer eiwit, bestaande uit vijf antigenefragmenten van vier verschillende Leishmania infantum (zymodeme Mon-1) eiwitten | |
ATE396205T1 (de) | Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe | |
GB2367061A (en) | Peptides | |
AR002742A1 (es) | Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn | |
HK1014498A1 (en) | Bpi-protein-products for depressed reticuloendothelial system function. | |
HUP9700676A2 (hu) | Rekombináns anti-Fas antitestek és az ezeket kódoló DNS | |
ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
DE69813620D1 (de) | Verwendung von citrullin enthaltenden peptiden, die von filaggrin abstammen, zur behandlung von autoimmunkrankheiten | |
DE69534633D1 (de) | Implantat und vektor zur behandlung von erworbenen krankheiten | |
DE59410423D1 (de) | Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose | |
DE69819922D1 (de) | 2-Amino-6-methyl-7-acetyl-tetralin und pharmazeutische Zusammensetzungen zur Vorbeugung und therapeutischen Behandlung von entzündlichen und/oder Autoimmunkrankheiten | |
ID23184A (id) | Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi | |
ATE245438T1 (de) | Verwendung von oligomerem matrixprotein aus knorpel zur behandlung von rheumatoider arthritis | |
SE9703287D0 (sv) | Peptides | |
DE69831487D1 (de) | Prismenförmiger, pyramidenförmiger oder ähnlicher behälter zur verteilung von chemikalien. | |
NZ505580A (en) | Method of treating immunodeficiences using neutrokine alpha |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1041997 Country of ref document: EP |